Evaluations of biomarkers associated with sensitivity to 5-fluorouracil and taxanes for recurrent/advanced breast cancer patients treated with capecitabine-based first-line chemotherapy-Reference-Cited by-同舟云学术

Evaluations of biomarkers associated with sensitivity to 5-fluorouracil and taxanes for recurrent/advanced breast cancer patients treated with capecitabine-based first-line chemotherapy

Published:2012-06 Issue:5 Volume:23 Page:534-542
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Zhao Hong-Yun,Huang He,Hu Zhi-Huang,Huang Yan,Lin Su-Xia,Tian Ying,Lin Tong-Yun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference47 articles.

1. Extending survival with chemotherapy in metastatic breast cancer.;OShaughnessy;Oncologist,2005

2. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds.;Heidelberger;Nature,1957

3. Moving forward with capecitabine: a glimpse of the future.;Biganzoli;Oncologist,2002

4. Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results.;Michalaki;Anticancer Drugs,2009

5. Safety and efficacy of moderate-dose capecitabine as first-line therapy in metastatic breast cancer.;Cortes-Funes;Expert Rev Anticancer Ther,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of degrading hydrogels in hepatocellular carcinoma drug delivery applications: A review;Journal of Drug Delivery Science and Technology;2024-05

2. Chitosan-based nanoscale delivery systems in hepatocellular carcinoma: Versatile bio-platform with theranostic application;International Journal of Biological Macromolecules;2023-07

3. Capecitabine—A “Permanent Mission” in Head and Neck Cancers “War Council”?;Journal of Clinical Medicine;2022-09-23

4. Evaluating genomic biomarkers associated with resistance or sensitivity to chemotherapy in patients with advanced breast and colorectal cancer;Journal of Oncology Pharmacy Practice;2020-08-26

5. Machine learning model to predict oncologic outcomes for drugs in randomized clinical trials;International Journal of Cancer;2020-08-19